Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
18 Jan 2023
Historique:
received: 18 12 2022
revised: 06 01 2023
accepted: 13 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

Neoadjuvant chemotherapy (NACT) for breast cancer (BC) often results in pathologic complete response (pCR), i.e., the complete elimination of visible cancer cells. It is unclear whether the use of ultrasensitive genetic methods may still detect residual BC cells in complete responders. Breast carcinomas arising in

Identifiants

pubmed: 36768191
pii: ijms24031870
doi: 10.3390/ijms24031870
pmc: PMC9914941
pii:
doi:

Substances chimiques

BRCA1 protein, human 0
BRCA1 Protein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Russia Science Foundation
ID : 22-15-00266

Références

Breast J. 2018 May;24(3):269-277
pubmed: 28929593
Cancer Chemother Pharmacol. 2021 Sep;88(3):439-450
pubmed: 34080040
Breast Cancer Res Treat. 2018 Aug;171(1):85-94
pubmed: 29725888
Clin Cancer Res. 2013 Dec 1;19(23):6360-70
pubmed: 24298066
J Clin Oncol. 2018 Aug 1;36(22):2281-2287
pubmed: 29791287
Breast Cancer Res Treat. 2014 Dec;148(3):675-83
pubmed: 25414026
Cancer Discov. 2012 Jun;2(6):503-11
pubmed: 22628410
Cancer Lett. 2017 Jul 1;397:127-132
pubmed: 28377179
Cancer Genet. 2021 Aug;256-257:165-178
pubmed: 34186498
JAMA Oncol. 2020 May 1;6(5):744-748
pubmed: 32163106
Ann Oncol. 2014 Jun;25(6):1128-36
pubmed: 24618153
Breast. 2003 Oct;12(5):320-7
pubmed: 14659147
J Clin Oncol. 2010 Jan 20;28(3):375-9
pubmed: 20008645
Breast Cancer Res Treat. 2016 May;157(1):157-65
pubmed: 27113739
Hered Cancer Clin Pract. 2021 Aug 28;19(1):36
pubmed: 34454564
J Clin Oncol. 2020 May 10;38(14):1539-1548
pubmed: 32097092
Cancer Lett. 2022 Feb 1;526:41-52
pubmed: 34808283
Breast Cancer (Auckl). 2020 Dec 16;14:1178223420980377
pubmed: 33402827
Nat Med. 2018 May;24(5):628-637
pubmed: 29713086
Clin Cancer Res. 2020 Jun 15;26(12):2838-2848
pubmed: 32046998
Lancet. 2014 Jul 12;384(9938):164-72
pubmed: 24529560
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47
pubmed: 22144499
J Clin Oncol. 2011 Oct 1;29(28):3739-46
pubmed: 21900106
JAMA Oncol. 2017 Oct 01;3(10):1378-1385
pubmed: 28715532

Auteurs

Anna P Sokolenko (AP)

Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, 197758 Saint Petersburg, Russia.
Department of Medical Genetics, St.-Petersburg Pediatric Medical University, 194100 Saint Petersburg, Russia.

Fedor V Moiseyenko (FV)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Aglaya G Iyevleva (AG)

Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, 197758 Saint Petersburg, Russia.
Department of Medical Genetics, St.-Petersburg Pediatric Medical University, 194100 Saint Petersburg, Russia.

Alexandr O Ivantsov (AO)

Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, 197758 Saint Petersburg, Russia.

Georgiy D Dolmatov (GD)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Ksenia V Shelekhova (KV)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Elizaveta V Gulo (EV)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Anastasya X Topal (AX)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Elizaveta V Artemieva (EV)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Nuriniso H Abduloeva (NH)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Nikita A Rysev (NA)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Daria A Barsova (DA)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Natalia V Levchenko (NV)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Nikita M Volkov (NM)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Vitaliy V Egorenkov (VV)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Vladimir M Moiseyenko (VM)

City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Evgeny N Imyanitov (EN)

Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, 197758 Saint Petersburg, Russia.
Department of Medical Genetics, St.-Petersburg Pediatric Medical University, 194100 Saint Petersburg, Russia.
City Cancer Center, 68A Leningradskaya Street, Pesochny, 197758 Saint Petersburg, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH